Brief: Invivyd Submits Request for Emergency Use Authorization to US FDA for VYD222

Invivyd

03/01/2024 12:16

Jan 3 (Reuters) - Invivyd Inc  IVVD.O :
    * INVIVYD SUBMITS REQUEST FOR EMERGENCY USE AUTHORIZATION
(EUA) TO
U.S. FDA FOR VYD222 FOR THE PRE-EXPOSURE PREVENTION OF COVID-19
IN IMMUNOCOMPROMISED ADULTS AND ADOLESCENTS
    * INVIVYD INC: COMPANY CONTINUES PREPARATIONS FOR POTENTIAL
COMMERCIAL LAUNCH IF EUA IS GRANTED
    * INVIVYD INC: VYD222 DEMONSTRATES CONTINUED IN VITRO
NEUTRALIZATION ACTIVITY AGAINST MAJOR SARS-COV-2 VARIANTS,
INCLUDING JN.1
    * INVIVYD INC: IF AUTHORIZED, INVIVYD AIMS TO HAVE VYD222
COMMERCIALLY AVAILABLE RAPIDLY THEREAFTER

Source text for Eikon:  ID:nGNX4ZxJMV 
Further company coverage:  IVVD.O 

 ((Reuters.Briefs@thomsonreuters.com;))